4.3 Article

Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass

期刊

BIOMARKERS
卷 14, 期 6, 页码 423-431

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/13547500903067744

关键词

Acute kidney injury; early detection; urinary biomarker; cardiac surgery

资金

  1. Norman Coplon Research Program of Satellite Healthcare, Inc.
  2. American Heart Association [0535367N]
  3. Earl P. Charlton Research Program of Tufts University School of Medicine
  4. National Institutes of Health [DK065102, DK077751, DK 39773, DK 074099, DK 072381, DK64075]
  5. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074099, R01DK039773, R37DK039773, K23DK065102, R33DK074099, R01DK072381, R03DK077751, K08DK064075] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The purpose of this study was to compare the performance of six candidate urinary biomarkers, kidney injury molecule (KIM)-1, N-acetyl-beta-D-glucosaminidase ( NAG), neutrophil gelatinase-associated lipocalin (NGAL), interleukin (IL)-18, cystatin C and alpha-1 microglobulin, measured 2 h following cardiopulmonary bypass (CPB) for the early detection of acute kidney injury (AKI) in a prospective cohort of patients undergoing cardiac surgery. A total of 103 subjects were enrolled; AKI developed in 13%. Urinary KIM-1 achieved the highest area under-the-receiver-operator-characteristic curve (AUC 0.78, 95% confidence interval 0.64-0.91), followed by IL-18 and NAG. Only urinary KIM-1 remained independently associated with AKI after adjustment for a preoperative AKI prediction score (Cleveland Clinic Foundation score; p = 0.02), or CPB perfusion time (p = 0.006). In this small pilot cohort, KIM-1 performed best as an early biomarker for AKI. Larger studies are needed to explore further the role of biomarkers for early detection of AKI following cardiac surgery.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据